AFT Pharmaceuticals May 13, 2016 veweb Press Release “Maxigesic® Partnered for Commonwealth of Independent States” Related Posts Excision BioTherapeutics "HIV Cure-Focused Excision BioTherapeutics Secures $10 Million in Seed Funding" Chemical Marker Reporter "SCHERING AG; acquired rights for Refludan" SCRIP World Pharmaceutical News "Lack of IPO Money now driving alliances"
Excision BioTherapeutics "HIV Cure-Focused Excision BioTherapeutics Secures $10 Million in Seed Funding"